表紙
市場調査レポート

Avipep Pty Ltdの製品パイプライン分析

Avipep Pty Ltd - Product Pipeline Review - 2015

発行 Global Markets Direct 商品コード 319963
出版日 ページ情報 英文 21 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
Avipep Pty Ltdの製品パイプライン分析 Avipep Pty Ltd - Product Pipeline Review - 2015
出版日: 2015年11月30日 ページ情報: 英文 21 Pages
概要

Avipep Pty Ltdはオーストラリアに本社を置くバイオテクノロジー企業です。前立腺癌、結腸直腸癌、乳癌の治療におけるアンメットニーズを対象とした診断薬および治療用製品の開発に注力しています。

当レポートでは、Avipep Pty Ltd における治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

目次

Avipep Pty Ltd の基本情報

  • Avipep Pty Ltd の概要
  • 主要情報
  • 企業情報

Avipep Pty Ltd :R&Dの概要

  • 主な治療範囲

Avipep Pty Ltd :パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品
  • パートナー製品
    • パートナー製品/併用療法モダリティ

Avipep Pty Ltd :パイプライン製品の概況

  • 初期段階にあるパイプライン製品
    • 前臨床段階の製品/併用療法モダリティ
    • 創薬段階の製品/併用療法モダリティ

Avipep Pty Ltd :薬剤プロファイル

  • AVP-4
  • AVP-5
  • AVP-6
  • AVP-7

Avipep Pty Ltd :パイプライン分析

  • 分子タイプ別

Avipep Pty Ltd :本社と子会社の所在地

  • 本社

付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC07828CDB

Summary

Global Markets Direct's, 'Avipep Pty Ltd - Product Pipeline Review - 2015', provides an overview of the Avipep Pty Ltd's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Avipep Pty Ltd's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Avipep Pty Ltd including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Avipep Pty Ltd's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Avipep Pty Ltd's pipeline products

Reasons to buy

  • Evaluate Avipep Pty Ltd's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Avipep Pty Ltd in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Avipep Pty Ltd's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Avipep Pty Ltd and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Avipep Pty Ltd
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Avipep Pty Ltd and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Avipep Pty Ltd Snapshot
    • Avipep Pty Ltd Overview
    • Key Information
    • Key Facts
  • Avipep Pty Ltd - Research and Development Overview
    • Key Therapeutic Areas
  • Avipep Pty Ltd - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Avipep Pty Ltd - Pipeline Products Glance
    • Avipep Pty Ltd - Early Stage Pipeline Products
      • Discovery Products/Combination Treatment Modalities
  • Avipep Pty Ltd - Drug Profiles
    • ADC-AVP04
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ADC-AVP06
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Conjugated Monoclonal Antibody for Oncology
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Avipep Pty Ltd - Pipeline Analysis
  • Avipep Pty Ltd - Pipeline Products by Target
  • Avipep Pty Ltd - Pipeline Products by Molecule Type
  • Avipep Pty Ltd - Pipeline Products by Mechanism of Action
  • Avipep Pty Ltd - Dormant Projects
  • Avipep Pty Ltd - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Avipep Pty Ltd, Key Information
  • Avipep Pty Ltd, Key Facts
  • Avipep Pty Ltd - Pipeline by Indication, 2015
  • Avipep Pty Ltd - Pipeline by Stage of Development, 2015
  • Avipep Pty Ltd - Monotherapy Products in Pipeline, 2015
  • Avipep Pty Ltd - Partnered Products in Pipeline, 2015
  • Avipep Pty Ltd - Partnered Products/ Combination Treatment Modalities, 2015
  • Avipep Pty Ltd - Discovery, 2015
  • Avipep Pty Ltd - Pipeline by Target, 2015
  • Avipep Pty Ltd - Pipeline by Molecule Type, 2015
  • Avipep Pty Ltd - Pipeline Products by Mechanism of Action, 2015
  • Avipep Pty Ltd - Dormant Developmental Projects,2015

List of Figures

  • Avipep Pty Ltd - Pipeline by Top 10 Indication, 2015
  • Avipep Pty Ltd - Pipeline by Top 10 Target, 2015
  • Avipep Pty Ltd - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top